Buscar
Congreso SOLACI

Búsqueda de: percutaneous coronary intervention

Si no está conforme con los resultados, inténtelo de nuevamente.
Chronic Coronary Syndromes

ESC 2024 | NOTION 3 Trial: Percutaneous Coronary Intervention in Patients with a Planned Transcatheter Aortic Valve Implantation

The relationship between aortic stenosis and valve disease is well established, with revascularization rates in this population...
Dr. Omar Tupayachi -
Ir
Institutional News

06/20 | SOLACI Webinar: Post-TAVI percutaneous coronary intervention. Register now

A new virtual educational event organized by the Latin American Society of Interventional Cardiology with the support...
solaci -
Ir
Antiplatelet

Is Using Drug-Eluting Balloons and Single Antiplatlelet Therapy Safe for Patients at High Risk for Bleeding Who Undergo Percutaneous Coronary Intervention?

The safety and efficacy of drug-coated balloons (DCB) has been established for the treatment of in-stent restenosis...
solaci -
Ir
Chronic Ischemic cardiopathy

Left Main Coronary Artery Percutaneous Coronary Intervention: Evolution and Results over Time

Left main coronary artery percutaneous coronary intervention (LMCA PCI) is a treatment option that is increasingly used...
solaci -
Ir
Coronary disease

SOLACI-CACI 2021 | Using the MLD MAX Algorithm in OCT-Guided PERCUTANEOUS CORONARY INTERVENTIONS – ABBOTT Symposium

✔️ Watch again the ABBOTT Symposium in the SOLACI-CACI 2021 Virtual Congress. ✔️ Topic: Using the MLD...
solaci -
Ir
Live Cases and Live in a Box Cases

Percutaneous coronary intervention

Live Case broadcasted  on June 9, 2016 by TBR productions of New York to Rio de Janeiro, from Columbia...
solaci -
Ir
Day 3

FAME II: Ischemia guided (IG) percutaneous coronary intervention (PCI) is superior to medical treatment.

Review: Stable coronary disease remains a scenario where percutaneous coronary intervention, (PCI), has not cleared the edges....
solaci -
Ir
Acute coronary syndromes

Percutaneous Coronary Intervention to Unprotected Left Main Stem In Different Coronary Syndromes

Original title: Comparative Outcomes After Unprotected Left Main Stem Percutaneous Coronary Intervention: A National Linked Cohort Study of...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad